Clinical Implications of Naples Prognostic Score for Patients with Resected Cholangiocarcinoma: A Real-World Experience

被引:4
|
作者
Xu, Benjie [1 ]
Zhu, Jiahao [1 ]
Wang, Ren [1 ]
Pang, Xiangyi [1 ]
Wang, Xin [1 ]
Lian, Jie [1 ,2 ]
Lu, Haibo [1 ,2 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Outpatient Chemotherapy, Harbin, Peoples R China
[2] Harbin Med Univ, Canc Hosp, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Naples prognostic score; cholangiocarcinoma; nomogram; overall survival; real-world experience; INFLAMMATION;
D O I
10.2147/JIR.S446735
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: The Nutritional Prognostic Score (NPS) is a composite indicator that effectively reflects the preoperative nutritional and inflammation status of patients. Its prognostic value has been extensively confirmed in various types of tumors. Our study aims to investigate the clinical implications of the NPS in the postoperative patients with cholangiocarcinoma (CCA). Patients and Methods: Data on clinicopathological characteristics were collected from CCA patients who underwent radical surgery between 2014 and 2019 at Harbin Medical University Cancer Hospital. NPS was calculated using relevant indicators to categorize the patients, and association of NPS with clinicopathological characteristics and survival outcomes were analyzed. To assess differences in survival rates between different groups, we utilized the Kaplan -Meier method. Independent prognostic risk factors were identified by Cox regression analysis. A CONomogram was created, and its accuracy in survival prediction was evaluated using receiver operating characteristic (ROC) curves. Independent verification was conducted in the validation group. Results: For this study, a cohort of 232 patients was enlisted and subsequently divided into training group (N=162) and validation group (N=70). An evident correlation was detected between NPS and preoperative malnutrition. Patients with higher NPS exhibited a worse overall survival (OS), with 5 -year OS rates of 79.1%, 33.1%, and 10.6%. Multivariate analysis revealed that NPS was an independent risk factor for OS in resected CCA patients (P<0.001). The NPS-based Nomogram was developed to accurately assess the risk of patients. Conclusion: The NPS was identified as a significant risk factor that impacts the prognosis of patients with resected CCA. In order to improve prognosis management, the NPS-based Nomogram has been demonstrated to be a precise and efficient tool.
引用
收藏
页码:655 / 667
页数:13
相关论文
共 50 条
  • [31] FAST SCORE REAL LIFE EXPERIENCE: IMPLICATIONS FOR CLINICAL PRACTICE
    Dasari, Kartheek
    Trannguyen, Minh
    Theethira, Thimmaiah
    Wong, Helen
    Roytman, Marina
    GASTROENTEROLOGY, 2021, 160 (06) : S827 - S827
  • [32] Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
    Tian, Meng-Xin
    Luo, Liu-Ping
    Liu, Wei-Ren
    Deng, Wei
    Yin, Jia-Cheng
    Jin, Lei
    Jiang, Xi-Fei
    Zhou, Yu-Fu
    Qu, Wei-Feng
    Tang, Zheng
    Wang, Han
    Tao, Chen-Yang
    Fang, Yuan
    Qiu, Shuang-Jian
    Zhou, Jian
    Liu, Jing-Feng
    Fan, Jia
    Shi, Ying-Hong
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 5187 - 5195
  • [33] Real-world implications of nonbiological factors with staging, clinical management, and prognostic prediction in pancreatic ductal adenocarcinoma
    Wang, Chao
    Chen, Haoda
    Deng, Xiaxing
    Xu, Wei
    Shen, Baiyong
    CANCER MEDICINE, 2023, 12 (01): : 651 - 662
  • [34] Real-World Experience of Ropeginterferon in Myeloproliferative Neoplasm Patients
    How, Chi-Joan
    Hobbs, Gabriela S.
    BLOOD, 2022, 140 : 12284 - 12285
  • [35] Real-world experience with ehealth telemonitoring in patients with hypertension
    Blok, S.
    Somsen, G. A.
    Stavrov, B.
    Tulevski, I. I.
    Van den Born, B. J. H.
    Winter, M. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 194 - 194
  • [36] Real-World experience with efgartigimod in patients with myasthenia gravis
    Fuchs, Lior
    Shelly, Shahar
    Vigiser, Ifat
    Kolb, Hadar
    Regev, Keren
    Schwartzmann, Yoel
    Vaknin-Dembinsky, Adi
    Dori, Amir
    Karni, Arnon
    JOURNAL OF NEUROLOGY, 2024, 271 (06) : 3462 - 3470
  • [37] INVASIVE PROCEDURES IN PATIENTS WITH HAEMOPHILIA ON EMICIZUMAB PROPHYLAXIS: REAL-WORLD CLINICAL EXPERIENCE IN SLOVENIA
    Rener, K.
    Pompe, B.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Zupan, I. Preloznik
    HAEMOPHILIA, 2022, 28 : 66 - 66
  • [38] Nationwide Etoricoxib Injection Clinical Experience (NICE): Real-World Evidence in Indian Patients
    Shetty, Umesh
    Neema, Pramod
    Muthu, S.
    Bhojwani, Divya
    Muchhala, Sameer
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [39] Tolerability and discontinuation rates in teriflunomide-treated patients A real-world clinical experience
    Alnajashi, Hind A.
    Alshamrani, Foziah J.
    Freedman, Mark S.
    NEUROSCIENCES, 2018, 23 (03) : 204 - 207
  • [40] Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience
    Veerapandiyan, Aravindhan
    Eichinger, Katy
    Guntrum, Debra
    Kwon, Jennifer
    Baker, Lindsay
    Collins, Erin
    Ciafaloni, Emma
    MUSCLE & NERVE, 2020, 61 (02) : 222 - 226